EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

2020263 citationsJournal Articlebronze Open Access

Authors

These statements provide guidance on diagnosis and management of rheumatic irAEs and aim to support future international collaborations.

Peace, Justice and strong institutions

Published in: Annals of the Rheumatic Diseases

Volume 80, Issue 1, pp. 36-48

Field-Weighted Citation Impact: 12.72